Esperion Therapeutics
ESPR
#7075
Rank
โ‚น28.80 B
Marketcap
โ‚น146.81
Share price
0.57%
Change (1 day)
42.77%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น58.43 B

According to Esperion Therapeutics's latest financial reports the company's total liabilities are โ‚น58.43 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น55.01 B16.28%
2022-12-31โ‚น47.30 B9.73%
2021-12-31โ‚น43.11 B31.4%
2020-12-31โ‚น32.81 B137%
2019-12-31โ‚น13.84 B209.37%
2018-12-31โ‚น4.47 B111.46%
2017-12-31โ‚น2.11 B87.48%
2016-12-31โ‚น1.12 B104.36%
2015-12-31โ‚น0.55 B-10.22%
2014-12-31โ‚น0.61 B136.87%
2013-12-31โ‚น0.25 B-80.8%
2012-12-31โ‚น1.35 B210.46%
2011-12-31โ‚น0.43 B
2002-12-31โ‚น0.60 B6.28%
2001-12-31โ‚น0.57 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น99.49 B 70.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น149.40 B 155.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.756 T 18,307.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น661.16 B 1,031.45%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น51.75 B-11.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.18 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA